The North America human drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
Key factors that are driving the growth of the market are rising need for medication among the populace, extensive research and developments projects undertaken by various market players to sustain their leadership in the market leading to launch of new and innovative products as well as a well-established pharmaceutical and medical device industry in the region.
Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to the increasing prevalence of the chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. Also, cancer is one of the leading cause of death in the North America region. Furthermore, the American Cancer Society (ACS) estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed. Targeted drug delivery system (TDDS) is a system, which delivers the drug in a controlled manner at a preselected biosite. Diabetes is a life-threatening chronic disease with no specialized cure. Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. For instance, according to the International Diabetes Federation (IDF), in 2017, a number of people with diabetes in North America was approximately 46 million, which is expected to reach 62 million in 2045. Thus, the increasing number of patients suffering from one or more chronic diseases is expected to boost the growth of drug delivery devices market over the coming years.
The US drug delivery systems market is expected to grow at the highest rate during the forecast period. The growth of this market is primarily driven by increasing prevalence of chronic diseases like diabetes, asthma, and others, a growing number of product launches by key players; and increasing use of drug delivery systems for disease management. The market for drug delivery systems in the US region is expected to reach US$ 741,528.96 Mn in 2027 from US$ 388,359.24 Mn in 2018. The growth rate of the market in the region is estimated to be 7.6% during the forecast period.
North America Drug Delivery Systems Market Revenue and Forecasts to 2027 ( US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION
By Route of Administration
- Oral
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-solid Oral Drugs
- Transmucosal
- Pulmonary Drug Delivery
- In-metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Buccal Drug Delivery
- Sublingual Drug Delivery
- Rectal Transmucosal Drug delivery
- Vaginal Transmucosal Drug Delivery
- Pulmonary Drug Delivery
- Injectable
- Conventional Injection Devices
- Self-Injection Devices
- Needle Free Injectors
- Pen Injectors
- Wearable Injectors
- Topical
- Semi-solid Topical Drug Delivery Formulations
- Liquid Topical Drug Delivery Formulations
- Solid Topical Drug Delivery Formulations
- Transdermal Patches
- Transdermal Gels
- Others
- Implantable
- Active Implantable
- Passive Implantable
- Ocular
- Eye Drops & Sprays
- Gels & Ointments
- Ocular Inserts
- Drug Coated Contact Lenses
NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Application
- Hospital & Clinics
- Home Care Settings
- Others
NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- U.S
- Canada
- Mexico
Companies Mentioned
- BD
- Novo Nordisk A/S
- 3M
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Route of Administration, Distribution Channel, and Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. North America Drug delivery systems Market – Key takeaways
PART 3. North America Drug delivery systems market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Drug Delivery Systems Market – By Route of Administration
3.2.2 North America Drug Delivery Systems Market – By Application
3.2.3 North America Drug Delivery Systems Market – By Distribution Channel
3.2.4 North America Drug Delivery Systems Market – By Country
3.3 PEST Analysis
PART 4. North America Drug delivery systems market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Number of Patients Suffering with Chronic Diseases
4.1.2 Increasing Adoption Towards Non-Invasive Drug Delivery Systems
4.2 Key Market Restraints
4.2.1 Product Recalls for Drug Delivery Systems
4.3 Key Market Opportunities
4.3.1 Rising Compliance of Patients
4.4 future Trends
4.4.1 Introduction of Novel Drug Delivery Systems
4.5 Impact analysis
PART 5. Drug delivery systems market – North America Analysis
5.1 North America Drug delivery systems market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
PART 6. drug Delivery systems Market – North America Regulatory Scenario
6.1 north america
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
PART 7. North America drug delivery systems market Analysis – By Route of Administration
7.1 Overview
7.2 NORTH AMERICA drug delivery systems MARKET, BY Route of Administration, 2018 & 2027 (%)
7.3 North America Drug delivery systems market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
7.4 oral drug delivery Market
7.4.1 Overview
7.4.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Solid Oral Drugs Market
7.4.3.1 Overview
7.4.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3.3 SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
7.4.4 Liquid Oral Drugs Market
7.4.4.1 Overview
7.4.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4.3 LIQUID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
7.4.5 Semi-solid Oral Drugs Market
7.4.5.1 Overview
7.4.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5.3 SEMI-SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
7.5 transmucosal drug delivery Market
7.5.1 Overview
7.5.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3 Pulmonary Drug Delivery Market
7.5.3.1 Overview
7.5.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3.3 PULMONARY DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
7.5.3.4 In-metered Dose Inhalers Market
7.5.3.4.1 Overview
7.5.3.4.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3.5 Dry Powder Inhalers Market
7.5.3.5.1 Overview
7.5.3.5.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3.6 Nebulizers Market
7.5.3.6.1 Overview
7.5.3.6.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4 Nasal Drug Delivery Market
7.5.4.1 Overview
7.5.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4.3 Nasal Spray Market
7.5.4.3.1 Overview
7.5.4.3.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4.4 Nasal Drops Market
7.5.4.4.1 Overview
7.5.4.4.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4.5 Nasal Gel Market
7.5.4.5.1 Overview
7.5.4.5.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
7.5.5 Buccal Drug Delivery Market
7.5.5.1 Overview
7.5.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.5.6 Sublingual Drug Delivery Market
7.5.6.1 Overview
7.5.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.5.7 Rectal Transmucosal Drug Delivery Market
7.5.7.1 Overview
7.5.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.5.8 Vaginal Transmucosal Drug Delivery Market
7.5.8.1 Overview
7.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Topical drug delivery Market
7.6.1 Overview
7.6.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.6.3 Semi-solid Topical Drug Delivery Formulations Market
7.6.3.1 Overview
7.6.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
7.6.4 Liquid Topical Drug Delivery Formulations Market
7.6.4.1 Overview
7.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
7.6.5 Solid Topical Drug Delivery Formulations Market
7.6.5.1 Overview
7.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
7.6.6 Transdermal Patches Market
7.6.6.1 Overview
7.6.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
7.6.7 Transdermal Gels Market
7.6.7.1 Overview
7.6.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
7.6.8 Others Market
7.6.8.1 Overview
7.6.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
7.7 injectable drug delivery Market
7.7.1 Overview
7.7.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.7.3 Conventional Injection Devices Market
7.7.3.1 Overview
7.7.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.7.4 Self-Injection Devices Market
7.7.4.1 Overview
7.7.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.7.4.3 Needle Free Injectors Market
7.7.4.3.1 Overview
7.7.4.3.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.7.4.4 Pen injectors Market
7.7.4.4.1 Overview
7.7.4.4.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.7.4.5 Wearable Injectors Market
7.7.4.5.1 Overview
7.7.4.5.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Implantable drug delivery Market
7.8.1 Overview
7.8.2 Implantable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.8.3 Active Implantable Market
7.8.3.1 Overview
7.8.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
7.8.4 Passive Implantable Market
7.8.4.1 Overview
7.8.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
7.9 ocular drug delivery Market
7.9.1 Overview
7.9.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.9.3 Eye Drops and Sprays Market
7.9.3.1 Overview
7.9.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
7.9.4 Gels & Ointments Market
7.9.4.1 Overview
7.9.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
7.9.5 Ocular Inserts Market
7.9.5.1 Overview
7.9.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
7.9.6 Drug Coated Contact Lens Market
7.9.6.1 Overview
7.9.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
PART 8. North America Drug delivery systems market Analysis – By Application
8.1 Overview
8.2 NORTH AMERICA drug delivery systems MARKET, BY application, 2018 & 2027 (%)
8.3 North America Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.4 homecare Settings market
8.4.1 Overview
8.4.2 North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 hospitals & clinics Market
8.5.1 Overview
8.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 others Market
8.6.1 Overview
8.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
PART 9. North America Drug delivery systems market Analysis – By Distribution Channel
9.1 Overview
9.2 NORTH AMERICA Drug delivery systems MARKET, BY distribution channel, 2018 & 2027 (%)
9.3 North America Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.4 hospital pharmacies market
9.4.1 Overview
9.4.2 North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 retail pharmacies market
9.5.1 Overview
9.5.2 North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 online pharmacies market
9.6.1 Overview
9.6.2 North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
PART 10. north america drug delivery market
10.1.1 Overview
10.1.2 North America Drug Delivery Market Revenue And Forecasts to 2027 (US$ Mn)
10.1.3 North America Drug Delivery Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
10.1.3.1 North America Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 North America Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.3 North America Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.4 North America Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.4.1 North America Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.5 North America Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.6 North America Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.7 North America Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.8 North America Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Drug delivery market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.5 North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.6 North America Drug delivery Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 US Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
10.1.8.1.1 US Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.2 US oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.3 US Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.4 US Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.4.1 US Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.5 US Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.6 US Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.7 US Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.1.8 US Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.2 US Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.8.3 US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.9 Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
10.1.10.1.1 Canada Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.2 Canada Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.3 Canada Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.4 Canada Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.5 Canada Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.6 Canada Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.7 Canada Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.8 Canada Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.1.9 Canada Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.2 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.10.3 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.11 Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12.1 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
10.1.12.1.1 Mexico Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.2 Mexico Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.3 Mexico Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.4 Mexico Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.5 Mexico Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.6 Mexico Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.7 Mexico Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.8 Mexico Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.1.9 Mexico Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.2 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.12.3 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
PART 11. drug delivery systems market – Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies done by the companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic developments
11.5.1 Overview
PART 12. Drug delivery systems market – Key company profiles
12.1 3M
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BD
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 novo nordisk a/s
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bausch Health Companies Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BAxter International, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Boehringer Ingelheim International GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novartis AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Information
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GlaxoSmithKline plc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Terumo Corporation
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product portfolio
12.10.5 SWOT ANALYSIS
12.10.6 KEY DEVELOPMENTS
12.11 Johnson & Johnson Services, Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Financial Overview
12.11.4 Product Portfolio
12.11.5 Swot Analysis
12.11.6 Key Developments
PART 13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
TABLE 1. North America Drug delivery systems market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 2. North America Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 3. North America drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 4. North America Drug delivery market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
TABLE 5. North America Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 6. North America oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 7. North America Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 8. North America Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 9. North America Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 10. North America topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 11. North America nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 12. North America Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 13. North America Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 14. North America Drug delivery market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 15. North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 16. US Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
TABLE 17. US Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 18. US oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 19. US Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 20. US Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 21. US Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 22. US topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 23. US nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 24. US Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 25. US Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 26. US Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 27. US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 28. Canada Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
TABLE 29. Canada Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 30. Canada oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 31. Canada Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 32. Canada Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 33. Canada Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 34. Canada topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 35. Canada nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 36. Canada Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 37. Canada Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 38. Canada Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 39. Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 40. Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
TABLE 41. Mexico Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 42. Mexico oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 43. Mexico Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 44. Mexico Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 45. Mexico Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 46. Mexico topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 47. Mexico nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 48. Mexico Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 49. Mexico Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 50. Mexico Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 51. Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 52. Organic Developments Done By Companies
TABLE 53. Inorganic developments done by Companies
TABLE 54. Glossary of Terms, Drug delivery systems market
LIST OF FIGURES
FIGURE 1. US Drug delivery systems market, Revenue (US$ Mn), By COuntry 2018 & 2027
FIGURE 2. north America drug delivery systems Market By Route of Administration, Market Share (%), 2018
FIGURE 3. north America drug delivery systems Market By Application, Market Share (%), 2018
FIGURE 4. North America Drug delivery systems Market By Distribution Channel, Market Share (%), 2018
FIGURE 5. Drug delivery systems market Segmentation
FIGURE 6. North America PEST Analysis
FIGURE 7. Drug delivery systems market impact analysis of drivers & Restraints
FIGURE 8. North America Drug delivery systems market – Revenue Forecasts and Analysis – 2018- 2027
FIGURE 9. North America drug delivery systems market, By Route of Administration, 2018 & 2027 (%)
FIGURE 10. Oral Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 11. transmucosal Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 12. IN-METERED DOSE INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 13. DRY POWDER INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 14. NEBULIZERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 15. NASAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. NASAL GEL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. BUCCAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. SUBLINGUAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. RECTAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. VAGINAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. topical Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 24. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 27. TRANSDERMAL PATCHES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 28. TRANSDERMAL GELS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 29. OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. injectable Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 31. CONVENTIONAL INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. NEEDLE FREE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 34. PEN INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 35. WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 36. Implantable drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 37. ACTIVE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. Passive Implantable MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. Ocular drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 40. Eye Drops And Spray MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. Gels & Ointments MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 42. Ocular Inserts MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 43. Drug Coated Contact Lens MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. North America drug delivery systems market By application, 2017 & 2025 (%)
FIGURE 45. North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 46. North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 47. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 48. North America drug delivery systems market By distribution channel, 2018 & 2027 (%)
FIGURE 49. North America HOSPITAL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 50. North America RETAIL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 51. North America online PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 52. North America Drug delivery market revenue Overview, by Country (2018) (us $ mn)
FIGURE 53. North America Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 54. North America Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)
FIGURE 55. US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 56. Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 57. Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 58. Comparative Company Analysis
FIGURE 59. Growth Strategies done by the companies in the Market, (%)
The List of Companies - North America Drug Delivery Systems Market
1. BD 2. Novo Nordisk A/S 3. 3M4. Boston Scientific Corporation 5. Bausch Health Companies Inc. 6. Baxter International, Inc. 7. Boehringer Ingelheim 8. Novartis AG9. GlaxoSmithKline plc. 10. Johnson & Johnson Services, Inc.The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Drug Delivery Systems Market
Jun 2019
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jun 2019
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jun 2019
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)